Zacks Analyst Blog Highlights: United Airlines, Pinnacle Airlines, ExpressJet, Frontier Airlines and ACADIA Pharmaceuticals.CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day, the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: United Airlines (Nasdaq:UAUA UAUA United Airlines, Inc (stock symbol) UAUA Unisys Airline Users Association ), Pinnacle Airlines (Nasdaq:PNCL PNCL Polish Committee of National Liberation (WWII) ), ExpressJet (NYSE NYSE See: New York Stock Exchange :XJT XJT Express Jet XJT Expansion Joint ), Frontier Airlines (Nasdaq:FRNT) and ACADIA Acadia (əkā`dēə), Fr. Acadie, region and former French colony, E Canada, encompassing modern Nova Scotia but also New Brunswick, Prince Edward Island, and coastal areas of E Maine. After an abortive 1604 settlement of St. Pharmaceuticals, Inc. (Nasdaq:ACAD ACAD Academy ACAD Academic ACAD AutoCAD (design/drafting development software by Autodesk) ACAD Acadia National Park (US National Park Service) ACAD Atherosclerotic Coronary Artery Disease ). See the latest posts to the Analyst Blog by visiting: http://at.zacks.com/?id=2673. Here are highlights from Thursday's Analyst Blog: Oil Prices Offset Terror Threat The effect on the airline stocks I cover has been mixed. In midday trading, United Airlines (Nasdaq:UAUA) is flat, Pinnacle Airlines (Nasdaq:PNCL) is down 2.7%, while ExpressJet (NYSE:XJT) and Frontier Airlines (Nasdaq:FRNT) are up 5.4% and 4.6%, respectively. I would guess that today's fall in oil prices has more than offset the shock of a terrorist threat. Don't forget the airlines are in much better shape than they were for 9-11. So any impact from terrorism will not be as gut-wrenching as the changes brought by 9-11. ACADIA a Steal at $6+ ACADIA Pharmaceuticals, Inc. (Nasdaq:ACAD) is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders Nervous system disorders A satisfactory classification of diseases of the nervous system should include not only the type of reaction (congenital malformation, infection, trauma, neoplasm, vascular diseases, and degenerative, metabolic, toxic, or deficiency . The company currently has five drug programs in clinical and preclinical development directed at large unmet medical needs and major commercial markets. We are maintaining our Buy rating based on our optimistic stance on mid-stage products ACP-103 and ACP-104. We expect the next few months to be a catalyst-rich period for ACADIA. We believe the shares offer an attractive investment opportunity up to the $16 level. See the latest posts to the Analyst Blog by visiting http://at.zacks.com/?id=2645. About Zacks Equity Research Zacks Equity Research provides the best of quantitative and qualitative analysis Qualitative Analysis Securities analysis that uses subjective judgment based on nonquantifiable information, such as management expertise, industry cycles, strength of research and development, and labor relations. to help investors know what stocks to buy and which to sell for the long-term. Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons. Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=2674. About Zacks Zacks.com is a property of Zacks Investment Research Zacks Investment Research A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms. , Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion